New developments in natural products-based anti-AIDS research

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Virology

Background:

• Natural products represent a rich source of diverse chemical scaffolds for drug discovery.
• Several classes of natural products, including terpenoids, alkaloids, and flavonoids, exhibit anti-HIV activity.
• The emergence of drug-resistant HIV strains necessitates the development of novel therapeutic agents with distinct mechanisms of action.

Purpose of the Study:

• To review and highlight anti-HIV natural products and their potential as chemotherapeutic leads.
• To discuss the drug discovery and development process for natural product-derived anti-HIV agents.
• To showcase the successful development of DSB (PA-457) as a prime example.

Main Methods:

• Literature review of natural products with reported anti-HIV activity.
• Analysis of compound classes including terpenoids, coumarins, alkaloids, polyphenols, tannins, and flavonoids.
• Case study of DSB (PA-457) development, from lead identification to clinical trials.

Main Results:

• Identification of multiple natural product classes with significant anti-HIV potential.
• Demonstration that natural products can offer novel mechanisms of action against HIV.
• DSB (PA-457), a modified betulinic acid derivative, has progressed to Phase II clinical trials as an HIV maturation inhibitor.

Conclusions:

• Natural products are a valuable resource for discovering novel anti-HIV drugs with unique structural features and mechanisms.
• The rational drug design and optimization process is crucial for translating promising natural product leads into clinical candidates.
• DSB (PA-457) exemplifies the successful application of this strategy, offering a new therapeutic avenue for HIV treatment.